The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Convertible Loan Notes update

13 Jun 2017 07:00

RNS Number : 8750H
Kin Group PLC
13 June 2017
 

Kin Group Plc / Epic: KIN / Index: AIM

 

RNS ANNOUNCEMENT: The information communicated in this announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

 

13 June 2017

 

KIN GROUP PLC ('KIN' OR 'THE COMPANY')

 

Convertible Loan Notes update

On 15 May 2017, Kin Group Plc (AIM: KIN), the AIM quoted digital wellness provider for corporate organisations trading as Kin Wellness, announced that it had agreed to issue convertible unsecured loan notes with a term of three years ("Notes"), to raise up to £1.125 million (before expenses) in four tranches, to Belastock Capital L.P., an overseas based institutional investor ("Belastock") to fund its general working capital requirements.

The issue of the Notes was subject to the terms and conditions summarised in the announcement dated 15 May. The first tranche of Notes with a nominal amount of £350,000 and a subscription price of £315,000 ("Tranche 1 Notes") were issued on 15 May 2017 with the remaining three tranches being issued at 60 day intervals thereafter.

One of the conditions attaching to the issue of subsequent Notes, which can be waived by Belastock, is that the closing bid price of the Company's ordinary shares (as reported by Bloomberg) falls below £0.001 (0.1 pence) for any five (5) consecutive trading days on or prior to the relevant issue date. The Company notes that this condition was not met at the close of business last night, 12 June 2017.

Notwithstanding this breach of the condition the Directors are pleased to report that Belastock has confirmed its ongoing support for the Company and that it is the current intention of Belastock to subscribe for the remaining tranches of the Notes as previously outlined. The second tranche of the Notes, which should raise approximately £255,000 (net of expenses), are due to be issued in mid-July.

Further announcements will be made as appropriate.

 

 

**ENDS**

 

For further information visit www.kinwellness.com

 

Contact:

 

Anna Gudmundson / Donald Stewart

 

Kin Group Plc

020 7449 4949

Mark Brady / Neil Baldwin

 

SPARK Advisory Partners Limited (Nominated Advisor)

 

020 3368 3551

Claire Louise Noyce

Hybridan LLP, Broker

020 3764 2341

 

Stephanie Forrest

T/F/D, Public Relations

07917 695755

 

Notes

About Kin Wellness

 

Kin Wellness provides digital wellness solutions that empower employers to create a positive culture of health within their organisation. By helping employees to embrace a healthier way of living, Kin Wellness can help maximise performance, reduce absenteeism, decrease the risk of chronic illness, and lower healthcare costs.

 

The Company's technological edge allows it to address holistic wellness by engaging both individuals and teams through intelligent, personalised interaction and gamification. This is an opportunity to make incremental behavioural changes that will last a lifetime. The progress of individuals translates to actionable data, meaningful reporting and insights that allow the organisation to monitor the impact of the programme and to refine it in order to achieve success.

 

Shares are admitted to trading on the London Stock Exchange AIM market under ticker KIN.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IODOKBDPCBKDOAD
Date   Source Headline
5th Oct 20224:35 pmRNS£10m Placing/Subscription ABB & Rex Retail Offer
21st Sep 20224:40 pmRNSSecond Price Monitoring Extn
21st Sep 20224:36 pmRNSPrice Monitoring Extension
21st Sep 20222:05 pmRNSSecond Price Monitoring Extn
21st Sep 20222:00 pmRNSPrice Monitoring Extension
20th Sep 202211:21 amRNSRevised Market Forecasts
20th Sep 20227:03 amRNSBidstack Expands US Operation with CRO Hire
20th Sep 20227:00 amRNSStrategy for Accelerated Growth in the US
12th Sep 20224:41 pmRNSSecond Price Monitoring Extn
12th Sep 20224:35 pmRNSPrice Monitoring Extension
31st Aug 20223:50 pmRNSNew IAB Intrinsic In-Game Measurement Standards
17th Aug 20227:00 amRNSSports Interactive, exclusive multi-year renewal
8th Aug 20227:00 amRNSInterim Results - six months ended 30 June 2022
11th Jul 20227:00 amRNSAsia-Pacific enterprise software deal
7th Jul 20224:40 pmRNSSecond Price Monitoring Extn
7th Jul 20224:35 pmRNSPrice Monitoring Extension
7th Jul 20227:00 amRNSTrading Update
17th Jun 20227:00 amRNSAppointment of Chairman Designate
24th May 202211:03 amRNS2022 AGM Results
23rd May 20227:00 amRNSHolding in Company
12th May 20229:05 amRNSSecond Price Monitoring Extn
12th May 20229:00 amRNSPrice Monitoring Extension
5th May 20227:00 amRNSBidstack adds four games from Highbrow Interactive
28th Apr 20225:15 pmRNSAnnual Report & Accounts and Notice of AGM
28th Apr 20227:00 amRNSBidstack Expands Portfolio With New Partnership
27th Apr 20227:00 amRNSFinal Results
8th Apr 202211:05 amRNSSecond Price Monitoring Extn
8th Apr 202211:00 amRNSPrice Monitoring Extension
24th Mar 20224:41 pmRNSSecond Price Monitoring Extn
24th Mar 20224:35 pmRNSPrice Monitoring Extension
21st Mar 202211:05 amRNSSecond Price Monitoring Extn
21st Mar 202211:00 amRNSPrice Monitoring Extension
18th Mar 202211:05 amRNSSecond Price Monitoring Extn
18th Mar 202211:00 amRNSPrice Monitoring Extension
9th Mar 20229:00 amRNSPrice Monitoring Extension
9th Mar 20227:00 amRNSBidstack partners with GroupM’s Xaxis
3rd Mar 20228:00 amRNSBidstack partners farm simulation game Goodville
25th Feb 20224:40 pmRNSSecond Price Monitoring Extn
25th Feb 20224:36 pmRNSPrice Monitoring Extension
22nd Feb 20227:00 amRNSBidstack adds 3 new titles from Game Tap Studios
8th Feb 20227:00 amRNSAppointment of CTO/CPO
24th Jan 20222:06 pmRNSSecond Price Monitoring Extn
24th Jan 20222:00 pmRNSPrice Monitoring Extension
19th Jan 20227:00 amRNSChange of Registered Office
10th Jan 20229:00 amRNSPrice Monitoring Extension
6th Jan 20224:41 pmRNSSecond Price Monitoring Extn
6th Jan 20224:36 pmRNSPrice Monitoring Extension
6th Jan 202211:06 amRNSSecond Price Monitoring Extn
6th Jan 202211:00 amRNSPrice Monitoring Extension
22nd Dec 20217:00 amRNSAdoption and Grant of LTIP Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.